Cross-regulation of protein stability by p53 and nuclear receptor SHP

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Yang, Zhihong ^a   Zhang, Yuxia ^a   Kemper, Jongsook Kim ^b   Wang, Li ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR RECEPTOR SHP; PROTEIN MDM2; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEINASE INHIBITION; UBIQUITINATION;

ANIMALS; CELL LINE, TUMOR; COLONIC NEOPLASMS; FIBROBLASTS; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; MICE; MICE, TRANSGENIC; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84862700968     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039789     Document Type: Article

References (45)

1. Zhang Y, Hagedorn CH, Wang L, (2011) Role of nuclear receptor SHP in metabolism and cancer. Biochim Biophys Acta 1812: 893-908.
2. Wang L, Lee YK, Bundman D, Han Y, Thevananther S, et al. (2002) Redundant pathways for negative feedback regulation of bile acid production. Dev Cell 2: 721-731.
3. Kerr TA, Saeki S, Schneider M, Schaefer K, Berdy S, et al. (2002) Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. Dev Cell 2: 713-720.
4. Wang L, Han Y, Kim CS, Lee YK, Moore DD, (2003) Resistance of SHP-null mice to bile acid-induced liver damage. J Biol Chem 278: 44475-44481.
5. Park YJ, Qatanani M, Chua SS, LaRey JL, Johnson SA, et al. (2008) Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasis. Hepatology 47: 1578-1586.
6. Huang J, Iqbal J, Saha PK, Liu J, Chan L, et al. (2007) Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver. Hepatology 46: 147-157.
7. Huang J, Tabbi-Anneni I, Gunda V, Wang L, (2010) Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism. Am J Physiol Gastrointest Liver Physiol 299: G1211-1221.
8. Pan X, Zhang Y, Wang L, Hussain MM, (2010) Diurnal regulation of MTP and plasma triglyceride by CLOCK is mediated by SHP. Cell Metab 12: 174-186.
9. Wang L, Huang J, Saha P, Kulkarni RN, Hu M, et al. (2006) Orphan receptor small heterodimer partner is an important mediator of glucose homeostasis. Mol Endocrinol 20: 2671-2681.
10. Park KG, Lee KM, Seo HY, Suh JH, Kim HS, et al. (2007) Glucotoxicity in the INS-1 rat insulinoma cell line is mediated by the orphan nuclear receptor small heterodimer partner. Diabetes 56: 431-437.
11. Tabbi-Anneni I, Cooksey R, Gunda V, Liu S, Mueller A, et al. (2010) Overexpression of nuclear receptor SHP in adipose tissues affects diet-induced obesity and adaptive thermogenesis. Am J Physiol Endocrinol Metab 298: E961-970.
12. Wang L, Liu J, Saha P, Huang J, Chan L, et al. (2005) The orphan nuclear receptor SHP regulates PGC-1alpha expression and energy production in brown adipocytes. Cell Metab 2: 227-238.
13. Song G, Park K, Wang L, (2009) Gene expression profiling reveals a diverse array of pathways inhibited by nuclear receptor SHP during adipogenesis. Int J Clin Exp Pathol 2: 275-285.
14. Zhang Y, Bonzo JA, Gonzalez FJ, Wang L, (2011) Diurnal regulation of the early growth response 1 (Egr-1) protein expression by hepatocyte nuclear factor 4alpha (HNF4alpha) and small heterodimer partner (SHP) cross-talk in liver fibrosis. J Biol Chem 286: 29635-29643.
15. Matsukuma KE, Bennett MK, Huang J, Wang L, Gil G, et al. (2006) Coordinated control of bile acids and lipogenesis through FXR-dependent regulation of fatty acid synthase. J Lipid Res 47: 2754-2761.
16. Matsukuma KE, Wang L, Bennett MK, Osborne TF, (2007) A key role for orphan nuclear receptor liver receptor homologue-1 in activation of fatty acid synthase promoter by liver X receptor. J Biol Chem 282: 20164-20171.
17. Datta S, Wang L, Moore DD, Osborne TF, (2006) Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase promoter by nuclear receptors liver receptor homologue-1 and small heterodimer partner: a mechanism for differential regulation of cholesterol synthesis and uptake. J Biol Chem 281: 807-812.
18. Suh JH, Huang J, Park YY, Seong HA, Kim D, et al. (2006) Orphan nuclear receptor small heterodimer partner inhibits transforming growth factor-beta signaling by repressing SMAD3 transactivation. J Biol Chem 281: 39169-39178.
19. Song G, Wang L, (2008) MiR-433 and miR-127 arise from independent overlapping primary transcripts encoded by the miR-433-127 locus. PLoS One 3: e3574.
20. Song G, Wang L, (2009) A conserved gene structure and expression regulation of miR-433 and miR-127 in mammals. PLoS One 4: e7829.
21. Song G, Wang L, (2009) Nuclear receptor SHP activates miR-206 expression via a cascade dual inhibitory mechanism. PLoS One 4: e6880.
22. Song G, Zhang Y, Wang L, (2009) MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation. J Biol Chem 284: 31921-31927.
23. Song G, Wang L, (2008) Transcriptional mechanism for the paired miR-433 and miR-127 genes by nuclear receptors SHP and ERRgamma. Nucleic Acids Res 36: 5727-5735.
24. Yang Z, Wang L, (2011) Regulation of microRNA expression and function by nuclear receptor signaling. Cell Biosci 1: 31.
25. Zhang Y, Yang Z, Whitby R, Wang L, (2011) Regulation of miR-200c by nuclear receptors PPARalpha, LRH-1 and SHP. Biochem Biophys Res Commun 416: 135-139.
26. Lee J, Padhye A, Sharma A, Song G, Miao J, et al. (2010) A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition. J Biol Chem 285: 12604-12611.
27. He N, Park K, Zhang Y, Huang J, Lu S, et al. (2008) Epigenetic inhibition of nuclear receptor small heterodimer partner is associated with and regulates hepatocellular carcinoma growth. Gastroenterology 134: 793-802.
28. Zhang Y, Xu P, Park K, Choi Y, Moore DD, et al. (2008) Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferation. Hepatology 48: 289-298.
29. Zhang Y, Soto J, Park K, Viswanath G, Kuwada S, et al. (2010) Nuclear receptor SHP, a death receptor that targets mitochondria, induces apoptosis and inhibits tumor growth. Mol Cell Biol 30: 1341-1356.
30. Zhang Y, Andrews GK, Wang L, (2012) Zinc-induced Dnmt1 expression involves antagonism between MTF-1 and nuclear receptor SHP. Nucleic Acids Res.
31. Zhang Y, Wang L, (2011) Nuclear receptor SHP inhibition of Dnmt1 expression via ERRgamma. FEBS Lett 585: 1269-1275.
32. Barak Y, Juven T, Haffner R, Oren M, (1993) mdm2 expression is induced by wild type p53 activity. Embo J 12: 461-468.
33. Haupt Y, Maya R, Kazaz A, Oren M, (1997) Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299.
34. Marine JC, Lozano G, (2010) Mdm2-mediated ubiquitylation: p53 and beyond. Cell Death Differ 17: 93-102.
35. Vousden KH, Prives C, (2009) Blinded by the Light: The Growing Complexity of p53. Cell 137: 413-431.
36. Wade M, Wang YV, Wahl GM, (2010) The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol 20: 299-309.
37. Yang Z, Zhang Y, Wang L, (2012) Mdm2 is a novel activator of ApoCIII promoter which is antagonized by p53 and SHP inhibition. Biochem Biophys Res Commun 417: 744-746.
38. Yang Z, Wang L, (2012) An autoregulatory feedback loop between Mdm2 and SHP that fine tunes Mdm2 and SHP stability. FEBS Lett 586: 1135-1140.
39. Zhou T, Zhang Y, Macchiarulo A, Yang Z, Cellanetti M, et al. (2010) Novel polymorphisms of nuclear receptor SHP associated with functional and structural changes. J Biol Chem 285: 24871-24881.
40. Zhao BX, Chen HZ, Lei NZ, Li GD, Zhao WX, et al. (2006) p53 mediates the negative regulation of MDM2 by orphan receptor TR3. Embo J 25: 5703-5715.
41. Kim DH, Lee JW, (2011) Tumor suppressor p53 regulates bile acid homeostasis via small heterodimer partner. Proc Natl Acad Sci U S A 108: 12266-12270.
42. Koinuma D, Shinozaki M, Komuro A, Goto K, Saitoh M, et al. (2003) Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7. Embo J 22: 6458-6470.
43. Sui G, Affar el B, Shi Y, Brignone C, Wall NR, et al. (2004) Yin Yang 1 is a negative regulator of p53. Cell 117: 859-872.
44. Neilsen PM, Cheney KM, Li CW, Chen JD, Cawrse JE, et al. (2008) Identification of ANKRD11 as a p53 coactivator. J Cell Sci 121: 3541-3552.
45. Montes de Oca Luna R, Wagner DS, Lozano G, (1995) Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378: 203-206.